Industry events

Speaker: Patricia Koochaki, Senior Principal, Patient Centred Outcomes

Friday, 20 October

Session: Clinical Care Applications

Title: Development of an observer reported outcome measure for obstructive sleep apnea

Time: 13:25pm

For further information, please visit the conference website.

 

 

Mackenzie Mellenbruch, Research Scientist (poster) | Poster,  “Use of Human Plasma as a Surrogate Matrix for Quantitation of Modified Protein Therapy across Multiple Tumor Tissues”

For further information, please visit the conference website.

 

Speaker: Martine Dehlinger Kremer, Vice President, Scientific Affairs

Session: DCTs in pediatric trials

For further information, please visit the conference website.

 

Speaker: Martine Dehlinger Kremer, Vice President, Scientific Affairs

Session: Presentation at the seventh session of the Human Medicines Symposium, HM7: Paediatric Investigational Plans

For further information, please visit the conference website.

 

Speaker: Nina Holst, Executive Director, Alliance Management

Join presentation with LEO Pharma:  "Building a flexible and efficient clinical operation organisation through a strategic partnership"

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Poster presentation

Title: What is Career Satisfaction to a Medical Writer?

Day/Time: Saturday, October 28, 8:00 – 9:15 AM and 10:30 – 11:00 AM

Speakers: Rob Panek and Greg Morehouse

Roundtable Discussion

Title: Understanding Early Clinical Writing

Day/Time: Friday, October 27, 7:30-8:45 AM.

Speaker: Rob Panek

Session title: Navigating the evolving transparency and disclosure landscape in 2023 and beyond

Date/Time: October 26th from 9:30 to 11:00 AM

Speaker: Dan Bilodeau

For further information, please visit the conference website.

 

Speakers: Will Maier, Vice President, Scientific Affairs & Bojana Mirosavljevic, Director Therapeutic Area

Roundtable: "Addressing patient concerns during rare disease gene therapy and genetic medicine development"

Speaker: Will Maier

Speaking session: "Early use of historical controls to improve rare disease drug development"

For further information, please visit the conference website.

 

Speaker: Missy Hansen, Associate Director             

Session: Assessing risk in your clinical trial using the Pediatric Risk Assessment Map (PRAM)

Panel discussion: Is DCT old news?

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Speaker: Sarah Johnston; Director, Medical Writing

Hall 11: Drafting your Plain Language Summaries: Hurdles to overcome and how to overcome them

Time and date: Monday, 6 November at 11:00–11:30

For further information, please visit the conference website.

 

Speaker: Georges McMIllan, Chief Commercial Officer | Commercial Services

Fireside Chat: Partnering for progress - Best practices to drive efficiency and effectiveness in drug development

Date and time: 8 Nov - 12:05 PM - 12:45 PM GMT

Speaker: Harpreet Gill, VP Decentralized Trials

Panel: How is Patient Engagement Evolving Clinically and Commercially?

Date and time: 08 Nov - 12:05 PM - 12:45 PM GMT

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Speaker: Martine Dehlinger Kremer, Vice President, Scientific Affairs

Session: EMA guidance perspectives on DCTs  

Time: 12:15 - 13:00
For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Speaker: Alexandre Malouvier, Senior Director, Therapeutic Area

Session: AI is already transforming clinical research and not everyone is prepared

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Speaker: Martine Dehlinger Kremer, Vice President, Scientific Affairs

Session: 24 November: BVMA symposium, moderation of session CTR/ CTIS

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

For further information, please visit the conference website.

 

Speaker: Patricia Anderson, Associate Director, Biostatistics 

Session: Cell and Gene Therapy: Introduction and Overview of Important Regulatory, Statistical and Operational Considerations

Date and time: Monday, 4 December 2023 from 14:00 pm - 17:00 pm

For further information, please visit the conference website.